Medications

Model Policy Guidelines for the Appropriate Use of Social Media and Social Networking in Medical Practice – April 2012

Posted on May 15, 2012. Filed under: Health Informatics, Medications | Tags: , |

Model Policy Guidelines for the Appropriate Use of Social Media and Social Networking in Medical Practice

A Policy Document of the Federation of State Medical Boards of the United States, Inc.
Adopted by the House of Delegates of the Federation of State Medical Boards of the United States, Inc., April 2012

“The Special Committee on Ethics and Professionalism was charged with providing ethical and professional guidance to the FSMB membership with regard to the use of electronic and digital media by physicians (and physician assistants, where appropriate) that may be used to facilitate patient care and nonprofessional interactions. Such electronic and digital media include, but are not limited to, e-mail, texting, blogs and social networks. The Committee’s proposed model guidelines contained in this report also focus on ways that physicians can protect the privacy and confidentiality of their patients as well as maintain a standard of professionalism in all social media and social networking interactions.”

Advertisements
Read Full Post | Make a Comment ( Comments Off on Model Policy Guidelines for the Appropriate Use of Social Media and Social Networking in Medical Practice – April 2012 )

Medication Management & Health IT – AHRQ – April 2011

Posted on May 6, 2011. Filed under: Health Informatics, Medications, Pharmacy | Tags: , |

Medication Management & Health IT – AHRQ – April 2011

U.S. Agency for Healthcare Research and Quality

“Structured Abstract
Objective: The objective of the report was to review the evidence on the impact of health information technology (IT) on all phases of the medication management process (prescribing and ordering, order communication, dispensing, administration and monitoring as well as education and reconciliation), to identify the gaps in the literature and to make recommendations for future research.

Data sources: We searched peer-reviewed electronic databases, grey literature, and performed hand searches. Databases searched included MEDLINE®, Embase, CINAHL (Cumulated Index to Nursing and Allied Health Literature), Cochrane Database of Systematic Reviews, International Pharmaceutical Abstracts, Compendex, Inspec (which includes IEEE Xplore), Library and Information Science Abstracts, E-Prints in Library and Information Science, PsycINFO, Sociological Abstracts, and Business Source Complete. Grey literature searching involved Internet searching, reviewing relevant Web sites, and searching electronic databases of grey literatures. AHRQ also provided all references in their e-Prescribing, bar coding, and CPOE knowledge libraries.

Methods: Paired reviewers looked at citations to identify studies on a range of health IT used to assist in the medication management process (MMIT) during multiple levels of screening (titles and abstracts, full text and final review for assignment of questions and data abstrction). Randomized controlled trials and cohort, case-control, and case series studies were independently assessed for quality. All data were abstracted by one reviewer and examined by one of two different reviewers with content and methods expertise.

Results: 40,582 articles were retrieved. After duplicates were removed, 32,785 articles were screened at the title and abstract phase. 4,578 full text articles were assessed and 789 articles were included in the final report. Of these, 361 met only content criteria and were listed without further abstraction. The final report included data from 428 articles across the seven key questions. Study quality varied according to phase of medication management. Substantially more studies, and studies with stronger comparative methods, evaluated prescribing and monitoring. Clinical decision support systems (CDSS) and computerized provider order entry (CPOE) systems were studied more than any other application of MMIT. Physicians were more often the subject of evaluation than other participants. Other health care professionals, patients, and families are important but not studied as thoroughly as physicians. These nonphysicians groups often value different aspects of MMIT, have diverse needs, and use systems differently. Hospitals and ambulatory clinics were well-represented in the literature with less emphasis placed on long-term care facilities, communities, homes, and nonhospital pharmacies. Most studies evaluated changes in process and outcomes of use, usability, and knowledge, skills, and attitudes. Most showed moderate to substantial improvement with implementation of MMIT. Economics studies and those with clinical outcomes were less frequently studied. Those articles that did address economics and clinical outcomes often showed equivocal findings on the effectiveness and cost-effectiveness of MMIT systems. Qualitative studies provided evidence of strong perceptions, both positive and negative, of the effects of MMIT and unintended consequences. We found little data on the effects of forms of medications, conformity, standards, and open source status. Much descriptive literature discusses implementation issues but little strong evidence exists. Interest is strong in MMIT and more groups and institutions will implement systems in the next decades, especially with the Federal Government’s push toward more health IT to support better and more cost-effective health care.

Conclusions: MMIT is well-studied, although on closer examination of the literature the evidence is not uniform across phases of medication management, groups of people involved, or types of MMIT. MMIT holds the promise of improved processes; clinical and economics studies and the understanding of sustainability issues are lacking.”

Read Full Post | Make a Comment ( None so far )

Innovating for health: patients, physicians, the pharmaceutical industry and the NHS

Posted on April 8, 2009. Filed under: Medications |

Innovating for health: patients, physicians, the pharmaceutical industry and the NHS

This report is the final product of a multi-sector working party convened to examine the relationship between the NHS, academic medicine and the pharmaceutical industry, and identify policies that would encourage a dynamic, productive and sustainable relationship between all three sectors. (Royal College of Physicians – publications)  February 2009   84 p.

Read Full Post | Make a Comment ( None so far )

Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence

Posted on April 8, 2009. Filed under: Medications, Patient Participation | Tags: , |

This guidance is about enabling patients to make informed choices by involving and supporting them in decisions about prescribed medicines. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence) to the NHS in England and Wales.   January 2009

Read Full Post | Make a Comment ( None so far )

Liked it here?
Why not try sites on the blogroll...